Synbiotic supplement for mild ulcerative colitis
Part of Digestive system clinical trials.
This study tests a new food supplement (a synbiotic, which combines good bacteria and food for them) to see if it helps control symptoms of ulcerative colitis, a type of inflammatory bowel disease. If you have mild to moderate ulcerative colitis, this supplement might help reduce inflammation and improve your gut health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old and of Chinese ethnicity.
- You have ulcerative colitis (a type of inflammatory bowel disease) with mild to moderate symptoms.
- Your ulcerative colitis medications have been at the same dose for at least 4 weeks.
- You have not used antibiotics, probiotics, or prebiotics in the last 4 weeks.
- You do not have a severe health condition, an ostomy, or a weakened immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a specially designed supplement that aims to restore healthy gut bacteria in people with mild-to-moderate ulcerative colitis. The goal is to reduce inflammation and improve symptoms like rectal bleeding and bowel urgency.
This trial tests whether adding a probiotic supplement and trace elements to your current treatment helps manage mild to moderate ulcerative colitis. It aims to see if these additions can improve symptoms and quality of life.
This trial tests a live bacteria powder (SK08) taken by mouth for ulcerative colitis. It aims to see if the bacteria can reduce inflammation and improve symptoms. You may qualify if standard treatments haven't worked well for you.
This study uses breath tests to see how a special diet changes gases in your gut that might affect ulcerative colitis. It aims to find out if these changes can help manage your condition.
This study tests an investigational medication called LY4268989 for adults with moderate to severe ulcerative colitis (UC). It's for people who have tried other treatments without success. The goal is to see if the drug can reduce inflammation and improve symptoms.
This trial tests a specific probiotic (a type of beneficial bacteria) to see if it can help people with mild to moderate ulcerative colitis by improving the balance of gut microbes. It may be an option if you have not used many advanced treatments before.
Hear when a new Inflammatory Bowel Disease (IBD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.